Light-based therapy for Parkinson’s disease mo
Author: Michael
Company targets US regulatory approval for ‘mi
Ossium Health CEO Kevin Caldwell on reengineerin
Alzprotect announced its lead candidate AZP2006 h
Epicore Biosystems CEO on harnessing thousands o
First patients dosed with novel NAD+ precursor d
New £4.
Celebrity-backed proactive health platform wants
CRISPR-modified human iPSC-microglia respond to
Coya’s biologic therapeutic aims to suppress c